For research use only. Not for therapeutic Use.
Neoanhydropodophyllol is a cyclolignan derivative, with antineoplastic activity. Neoanhydropodophyllol displays cytotoxicity against several cancer cells (leukemia, lung carcinoma and colon carcinoma)[1].
| Catalog Number | I044890 |
| CAS Number | 62287-47-2 |
| Synonyms | [(1R,11R,12R,15R)-11-(3,4,5-trimethoxyphenyl)-5,7,14-trioxatetracyclo[10.2.1.02,10.04,8]pentadeca-2,4(8),9-trien-15-yl]methanol |
| Molecular Formula | C22H24O7 |
| Purity | ≥95% |
| InChI | InChI=1S/C22H24O7/c1-24-18-4-11(5-19(25-2)22(18)26-3)20-12-6-16-17(29-10-28-16)7-13(12)21-14(8-23)15(20)9-27-21/h4-7,14-15,20-21,23H,8-10H2,1-3H3/t14-,15-,20+,21-/m0/s1 |
| InChIKey | GAPFRQMOPFLDIS-YJPXFSGGSA-N |
| SMILES | COC1=CC(=CC(=C1OC)OC)C2C3COC(C3CO)C4=CC5=C(C=C24)OCO5 |
| Reference | [1]. M Gordaliza, et al. Cytotoxic cyclolignans related to podophyllotoxin. Farmaco. 2001 Apr;56(4):297-304. |
